Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Fleming, TR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 36 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fleming, TR; Lin, DY
      Survival analysis in clinical trials: Past developments and future directions

      BIOMETRICS
    2. Fleming, TR
      Design and interpretation of equivalence trials

      AMERICAN HEART JOURNAL
    3. Fleming, TR
      Surrogate end points in cardiovascular disease trials

      AMERICAN HEART JOURNAL
    4. Tabet, SR; Surawicz, C; Horton, S; Paradise, M; Coletti, AS; Gross, M; Fleming, TR; Buchbinder, S; Haggitt, RC; Levine, H; Kelly, CW; Celum, CL
      Safety and toxicity of Nonoxynol-9 gel as a rectal microbicide

      SEXUALLY TRANSMITTED DISEASES
    5. Psaty, BM; Weiss, NS; Furberg, CD; Koepsell, TD; Siscovick, DS; Rosendaal, FR; Smith, NL; Heckbert, SR; Kaplan, RC; Lin, DY; Fleming, TR; Wagner, EH
      Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    6. Fleming, TR
      Issues in the design of clinical trials: Insights from the trastuzumab (Herceptin) experience

      SEMINARS IN ONCOLOGY
    7. Goldberg, RM; Fleming, TR
      Surgery for recurrent colon cancer - Response

      ANNALS OF INTERNAL MEDICINE
    8. SHARPLES K; FLEMING TR; MACMAHON S; MOORE A; REID I; SCOGGINS B
      MONITORING CLINICAL-TRIALS

      New Zealand medical journal
    9. GOLDBERG RM; FLEMING TR; TANGEN CM; MOERTEL CG; MACDONALD JS; HALLER DG; LAURIE JA
      SURGERY FOR RECURRENT COLON-CANCER - STRATEGIES FOR IDENTIFYING RESECTABLE RECURRENCE AND SUCCESS RATES AFTER RESECTION

      Annals of internal medicine
    10. LIN DY; FLEMING TR; DEGRUTTOLA V
      ESTIMATING THE PROPORTION OF TREATMENT EFFECT EXPLAINED BY A SURROGATE MARKER

      Statistics in medicine
    11. SHEN Y; FLEMING TR
      WEIGHTED MEAN SURVIVAL TEST STATISTICS - A CLASS OF DISTANCE TESTS FOR CENSORED SURVIVAL-DATA

      Journal of the Royal Statistical Society. Series B: Methodological
    12. MARTINO RL; FLEMING TR; MORRELL LM; ARDALAN B; RICHMAN SP; MACDONALD JS
      PHASE-II TRIAL OF LOW-DOSE N-(PHOSPHONACETYL)-DISODIUM L-ASPARTIC ACID AND HIGH-DOSE 24-HOUR INFUSIONAL 5-FLUOROURACIL IN ADVANCED GASTRIC ADENOCARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Investigational new drugs
    13. FLEMING TR; DEMETS DL
      SURROGATE END-POINTS IN CLINICAL-TRIALS - ARE WE BEING MISLED

      Annals of internal medicine
    14. FLEMING TR; NEATON JD; GOLDMAN A; DEMETS DL; LAUNER C; KORVICK J; ABRAMS D; BEERS D; LOVELESS K; MARTINEZ N; MESARD CA; REVES RR; ROUFF JA; KLEIN T; MCDONALD R; SLOTTEN R; BROSGART C; DREW L; FESSEL J; HUDSON R; LOPEZ C; THOMPSON S; KUMI JO; MASTROPOLAK D; SARAVOLATZ LD; KERKERING TM; HIGGINSON RA; GERNON L; BAR M; MENDEZ D; ERNST J; SCOTT J; FINLEY B; WARD D; WISNIEWSKI T; BRANDON W; WALTER J; CALHOUN C; EBRIGHT JR; SCHUMAN P; BINCSIK A; SWANSON K; WINSLOW D; SHERIDAN A; TAYLOR V; PEREZ G; ELSADR W; GUITY C; JULEAU J; SALVATI S; DOWLING C; SALVADOR GI; BURNS AJ; LAM SH; CHILDRESS JF; DEETS DL; FLEMING TR; MEYER KH; POLLARD RB; OFALLON JR; RAHAL JJ; WALTERS L; WHITNEYWILLIAMS P; WHITLEY RJ
      INSIGHTS FROM MONITORING THE CPCRA DIDANOSINE ZALCITABINE TRIAL

      Journal of acquired immune deficiency syndromes and human retrovirology
    15. MACDONALD JS; FLEMING TR; PETERSON RF; BERENBERG JL; MCCLURE S; CHAPMAN RA; EYRE HJ; SOLANKI D; CRUZ AB; GAGLIANO R; ESTES NC; TANGEN CM; RIVKIN S
      ADJUVANT CHEMOTHERAPY WITH 5-FU, ADRIAMYCIN, AND MITOMYCIN-C (FAM) VERSUS SURGERY ALONE FOR PATIENTS WITH LOCALLY ADVANCED GASTRIC ADENOCARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Annals of surgical oncology
    16. BROWN TD; FLEMING TR; GOODMAN PJ; MACDONALD JS; PUGH RP; OROURKE T
      A RANDOMIZED TRIAL OF 2 SCHEDULES OF TRIMETREXATE VERSUS 5-FLUOROURACIL IN ADVANCED COLORECTAL-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Anti-cancer drugs
    17. LEICHMAN CG; FLEMING TR; MUGGIA FM; TANGEN CM; ARDALAN B; DOROSHOW JH; MEYERS FJ; HOLCOMBE RF; WEISS GR; MANGALIK A; MACDONALD JS
      PHASE-II STUDY OF FLUOROURACIL AND ITS MODULATION IN ADVANCED COLORECTAL-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Journal of clinical oncology
    18. MOERTEL CG; FLEMING TR; MACDONALD JS; HALLER DG; LAURIE JA; TANGEN CM; UNGERLEIDER JS; EMERSON WA; TORMEY DC; GLICK JH; VEEDER MH; MAILLIARD JA
      INTERGROUP STUDY OF FLUOROURACIL PLUS LEVAMISOLE AS ADJUVANT THERAPY FOR STAGE-II DUKES B2 COLON-CANCER

      Journal of clinical oncology
    19. FABIAN C; GIRI S; ESTES N; TANGEN CM; POPLIN E; VOGEL S; GOODWIN W; RIVKIN S; FLEMING TR; MACDONALD JS
      ADJUVANT CONTINUOUS-INFUSION 5-FU, WHOLE-ABDOMINAL RADIATION, AND TUMOR BED BOOST IN HIGH-RISK STAGE-III COLON-CARCINOMA - A SOUTHWEST-ONCOLOGY-GROUP PILOT-STUDY

      International journal of radiation oncology, biology, physics
    20. DEMETS DL; FLEMING TR; WHITLEY RJ; CHILDRESS JF; ELLENBERG SS; FOULKES M; MAYER KH; OFALLON J; POLLARD RB; RAHAL JJ; SANDE M; STRAUS S; WALTERS L; WHITLEYWILLIAMS P
      THE DATA AND SAFETY MONITORING BOARD AND ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME (AIDS) CLINICAL-TRIALS

      Controlled clinical trials
    21. FLEMING TR; BROWN TD; ROSS SW; MACDONALD JS
      PHASE-II TRIAL OF TRIMETREXATE IN ADVANCED ESOPHAGEAL CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Investigational new drugs
    22. SCHAPER C; FLEMING TR; SELF SG; RIDA WN
      STATISTICAL ISSUES IN THE DESIGN OF HIV VACCINE TRIALS

      Annual review of public health
    23. BERENBERG JL; TANGEN C; MACDONALD JS; HUTCHINS LF; NATALE RB; OISHI N; GUY JT; FLEMING TR
      PHASE-II STUDY OF 5-FLUOROURACIL AND FOLINIC ACID IN THE TREATMENT OFPATIENTS WITH ADVANCED GASTRIC-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Cancer
    24. ANDERSON GL; FLEMING TR
      MODEL MISSPECIFICATION IN PROPORTIONAL HAZARDS REGRESSION

      Biometrika
    25. GRAMBSCH PM; THERNEAU TM; FLEMING TR
      DIAGNOSTIC PLOTS TO REVEAL FUNCTIONAL FORM FOR COVARIATES IN MULTIPLICATIVE INTENSITY MODELS

      Biometrics
    26. MOERTEL CG; FLEMING TR; MACDONALD JS; HALLER DG; LAURIE JA; TANGEN CM; UNGERLEIDER JS; EMERSON WA; TORMEY DC; GLICK JH; VEEDER MH; MAILLIARD JA; GRAFF J
      FLUOROURACIL PLUS LEVAMISOLE AS EFFECTIVE ADJUVANT THERAPY AFTER RESECTION OF STAGE-III COLON-CARCINOMA - A FINAL REPORT

      Annals of internal medicine
    27. FLEMING TR; PRENTICE RL; PEPE MS; GLIDDEN D
      SURROGATE AND AUXILIARY END-POINTS IN CLINICAL-TRIALS, WITH POTENTIALAPPLICATIONS IN CANCER AND AIDS RESEARCH

      Statistics in medicine
    28. FLEMING TR
      SURROGATE MARKERS IN AIDS AND CANCER TRIALS

      Statistics in medicine
    29. BUKOWSKI RM; TANGEN CM; PETERSON RF; TAYLOR SA; RINEHART JJ; EYRE HJ; RIVKIN SE; FLEMING TR; MACDONALD JS
      PHASE-II TRIAL OF DIMETHYLTRIAZENOIMIDAZOLE CARBOXAMIDE IN PATIENTS WITH METASTATIC CARCINOID - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Cancer
    30. LIN DY; FLEMING TR; WEI JL
      CONFIDENCE BANDS FOR SURVIVAL CURVES UNDER THE PROPORTIONAL HAZARDS MODEL

      Biometrika
    31. MOERTEL CG; FLEMING TR; MACDONALD JS; HALLER DG; LAURIE JA
      HEPATIC TOXICITY ASSOCIATED WITH FLUOROURACIL PLUS LEVAMISOLE ADJUVANT THERAPY

      Journal of clinical oncology
    32. FLEMING TR; DEMETS DL
      MONITORING OF CLINICAL-TRIALS - ISSUES AND RECOMMENDATIONS

      Controlled clinical trials
    33. LEICHMAN CG; TANGEN C; MACDONALD JS; LEIMERT T; FLEMING TR
      PHASE-II TRIAL OF AMONAFIDE IN ADVANCED PANCREAS CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Investigational new drugs
    34. HARVEY WH; FLEMING TR; GOODMAN PJ; HARVEY JH; RIVKIN SE; MACDONALD JS
      PHASE-II STUDY OF TRIMETREXATE IN PREVIOUSLY UNTREATED PATIENTS WITH HEPATOCELLULAR-CARCINOMA - SOUTHWEST-ONCOLOGY-GROUP STUDY 8712

      Investigational new drugs
    35. MOERTEL CG; FLEMING TR; MACDONALD JS; HALLER DG; LAURIE JA; TANGEN C
      AN EVALUATION OF THE CARCINOEMBRYONIC ANTIGEN (CEA) TEST FOR MONITORING PATIENTS WITH RESECTED COLON-CANCER

      JAMA, the journal of the American Medical Association
    36. KOSOROK MR; FLEMING TR
      USING SURROGATE FAILURE TIME DATA TO INCREASE COST-EFFECTIVENESS IN CLINICAL-TRIALS

      Biometrika


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/21 alle ore 08:02:11